-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Buy on Telix Pharmaceuticals, Lowers Price Target to $22

Benzinga·07/07/2026 18:25:16
Listen to the news
Citigroup analyst Laura Sutcliffe maintains Telix Pharmaceuticals (NASDAQ:TLX) with a Buy and lowers the price target from $22.5 to $22.